Attitudes Towards Back and Back Pain in German-speaking Switzerland

January 22, 2024 updated by: Fabian Pfeiffer, Zurich University of Applied Sciences

Assessing the Cross-cultural Validity and Reliability of the German Version of the Back Pain Attitudes Questionnaire (Back-PAQ_G) Within the German-speaking Swiss Population

This research aims to assess the cross-cultural validity and reliability of the German version of the Back-PAQ (Back-PAQ_G) within the German-speaking Swiss population.

The target population for this study includes individuals with and without back pain and primary care healthcare professionals. This includes physicians, physiotherapists, and nurses. The participants will be asked to fill out the Back-PAQ_G and similiar questionnaires online.

Study Overview

Status

Enrolling by invitation

Conditions

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Fabian Pfeiffer, MSc
  • Phone Number: +41 58 934 73 02
  • Email: pfer@zhaw.ch

Study Contact Backup

Study Locations

  • Switzerland
      • Winterthur, Switzerland, 8400
        • Kantonsspital Winterthur (KSW)
    • Baselland
      • Muttenz, Baselland, Switzerland, 4132
        • 4 Balance Zentrum für Physiotherapie und medizinisches Training

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The target population for this study includes individuals with and without back pain and primary care healthcare professionals. This includes physicians, physiotherapists, and nurses.

Description

Inclusion Criteria:

  • Living within the German-speaking part of Switzerland

Exclusion Criteria:

  • Insufficient German language skills

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Back Pain and Attitudes Questionnaire
Time Frame: baseline
The Back-PAQ_G contains 34 statements about the lower back and back pain that have to be rated as "true", "uncertain" or "false". Scores range from 34 to 170. The higher the score, the more unhelpful attitudes toward the back and back pain are present. Participants will receive the German version of the Back-PAQ (Back-PAQ_G).
baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tampa Scale of Kinesiophobia
Time Frame: baseline
The TSK examines fear of movement and injury. The TSK applies to individuals with and without pain. The scores range from 11 to 44. A higher score on the completed questionnaire implies high kinesiophobia and an existing somatic focus. The participants of the study receive the German version of TSK-GV with eleven questions.
baseline
Fear Avoidance Belief Questionnaire
Time Frame: baseline
The FABQ examines fear avoidance attitudes about the effect of work and activity on lower back pain. The questionnaire applies to individuals with low back pain. The maximum score is 96. A high score indicates a strong fear-avoidance posture for low back pain. Participants with current low back pain receive the validated German version of the FABQ with 16 questions.
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Zurich University of Applied Sciences

Investigators

  • Principal Investigator: Fabian Pfeiffer, MSc, ZHAW, Department Gesundheit, Institut für Physiotherapie

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 3, 2023

Primary Completion (Estimated)

March 1, 2024

Study Completion (Estimated)

March 1, 2024

Study Registration Dates

First Submitted

July 17, 2023

First Submitted That Met QC Criteria

July 17, 2023

First Posted (Actual)

July 27, 2023

Study Record Updates

Last Update Posted (Actual)

January 23, 2024

Last Update Submitted That Met QC Criteria

January 22, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Back-PAQ_G

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe